Pt Hetzer Medical Stock Current Valuation
| MEDS Stock | 50.00 0.00 0.00% |
Valuation analysis of PT Hetzer Medical helps investors to measure PT Hetzer's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that PT Hetzer's price fluctuation is very steady at this time. Calculation of the real value of PT Hetzer Medical is based on 3 months time horizon. Increasing PT Hetzer's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
PT Hetzer's intrinsic value may or may not be the same as its current market price of 50.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 50.0 | Real 50.0 | Hype 50.0 | Naive 50.0 |
The intrinsic value of PT Hetzer's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence PT Hetzer's stock price.
Estimating the potential upside or downside of PT Hetzer Medical helps investors to forecast how MEDS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PT Hetzer more accurately as focusing exclusively on PT Hetzer's fundamentals will not take into account other important factors: PT Hetzer Medical Company Current Valuation Analysis
PT Hetzer's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, PT Hetzer Medical has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The current valuation for all Indonesia stocks is 100.0% higher than that of the company.
PT Hetzer Medical is currently under evaluation in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Instruments & Supplies industry is now estimated at about 0.0. PT Hetzer adds roughly 0.0 in current valuation claiming only tiny portion of all equities under Medical Instruments & Supplies industry.MEDS Fundamentals
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.12 % | |||
| Shares Outstanding | 1.56 B | |||
| Shares Owned By Insiders | 8.00 % | |||
| Price To Sales | 5.97 X | |||
| Revenue | 43.99 B | |||
| Gross Profit | 53.98 B | |||
| EBITDA | 7.68 B | |||
| Book Value Per Share | 45.78 X | |||
| Number Of Employees | 25 | |||
| Market Capitalization | 231.25 B |
About PT Hetzer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PT Hetzer Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Hetzer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Hetzer Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in MEDS Stock
PT Hetzer financial ratios help investors to determine whether MEDS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDS with respect to the benefits of owning PT Hetzer security.